Tonix Pharmaceuticals(us:TNXP)

18.88

-3.58%

Updated on 2025-05-06

Open:19.60
Close:18.88
High:20.38
Low:18.55
Prev Close:19.58
Volume:526705.00
Turnover:10.21M
Turnover Ratio:7.05%
Shares:7.47M
MarketCap:141.10M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-30423275053.33%101019
2024-03-31493754350.51%13819
2023-12-31401442606224.61%9106
2023-09-3037369453420.80%7513
2023-06-303610233509.51%4199
2023-03-314112124831.90%11214
2022-12-3155924208812.08%10822
2022-09-3060557414810.45%91422
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Sabby Management, Llc1529990.21%5626058.16%
2024-03-31Alyeska Investment Group, L.P.625000.08%-21959-26.00%
2024-03-31Marshall Wace, Llp508570.07%-24143-32.19%
2024-03-31Rosalind Advisors, Inc.281530.04%0
2024-03-31Vanguard Group Inc165890.02%391930.93%
2024-03-31Armistice Capital, Llc152810.02%-102532-87.03%
2024-03-31Geode Capital Management, Llc124600.02%9128273.95%
2024-03-31Acadian Asset Management Llc104800.01%7573260.51%
2024-03-31Prudential Financial Inc42130.01%4213
2024-03-31Renaissance Technologies Llc38980.01%-3650-48.36%

About

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.
Address:26 Main Street,Suite 101

Market Movers